Efecto del trastorno afectivo en el rendimiento cognitivo del paciente con Fibromialgia

La Fibromialgia (FM) es un síndrome de etiología desconocida y multifactorial. Afecta a un número elevado de personas y produce un impacto socieconómico de primera magnitud. Un síntoma, comúnmente expresado en la entrevista clínica y que genera preocupación en el enfermo, es la merma cognitiva. No existe un consenso sobre la existencia de déficits cognitivos, ni de la implicación del trastorno depresivo asociado a la enfermedad. En el presente estudio, se pretende definir el perfil neuropsicológico asociado a la FM y la implicación del trastorno afectivo en el mismo. Material y métodos: 37 enfermos (100% mujeres), edad media de 46±7,69 años, diagnosticadas de FM (Criterios ACR). Se administran tests de ansiedad y depresión y pruebas neuropsicológicas (funciones ejecutivas, amnésicas y velocidad en el procesamiento de la información). Resultados: El 62,2 % de pacientes presentan trastorno afectivo y el 89,2 % ansioso. Se constata una influencia del estado afectivo estadísticamente significativa en las pruebas de dígitos directos e inversos, y en el test de evocación mnésica. Conclusiones. El perfil de afectación cognitiva en pacientes con Fibromialgia y Trastorno Afectivo asociado se caracteriza por una disminución en el rendimiento atencional, en la memoria de trabajo y en la evocación mnésica

Central sensitization in knee osteoarthritis and fibromyalgia : beyond depression and anxiety

This work was partially supported by the Ministry of Economy and Competitiveness (Grant PSI2014-53524-P and PSI2017-83777) and the Agency of University and Research Funding Management of the Catalonia Government (Research Groups SGR2017-1198). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was partially supported by the Ministry of Economy and Competitiveness (Grant PSI2014-53524-P and PSI2017-83777) and the Agency of University and Research Funding Management of the Catalonia Government (Research Groups SGR2017-1198).Objectives: To determine the psychopathological profile of patients with central sensitization (CS) in a sample of knee osteoarthritis, with and without CS, and fibromyalgia, and to compare their psychopathological profiles. Methods The final sample consists of 19 patients with osteoarthritis and CS (mean 66.37 years ± 8.77), 41 osteoarthritis patients without CS (mean 66.8 ± 7.39 years), 47 fibromyalgia patients (mean 46.47 years ± 7.92) and 26 control subjects (mean 51.56 years ± 11.41). The psychopathological profile was evaluated with the Millon Multiaxial Clinical Inventory. Results The average score of MCMI-III reflect higher scores in the fibromyalgia and osteoarthritis-CS groups. Patients with osteoarthritis-CS are more likely to report larger scores in Borderline and Major Depression scales. Fibromyalgia patients are more likely to report more increased scores in Somatoform and Major Depression, versus osteoarthritis-CS group. Fibromyalgia patients versus osteoarthritis without CS are more likely to report higher scores in Schizoid, Depression, Histrionic, Sadistic, Borderline, Somatoform, Posttraumatic Stress Disorder and Major Depression scales. Discussion Patients with CS have less differences in their psychopathological profiles as well as in both osteoarthritis groups and greatest differences are obtained between the fibromyalgia and osteoarthritis without CS, so perhaps presence of CS is the key to differentiate those groups and not chronic pain. An exhaustive assessment brings more accurate psychopathological profiles, thus better psychological treatment could be applied

Central sensitization in knee osteoarthritis and fibromyalgia: Beyond depression and anxiety

Objectives: To determine the psychopathological profile of patients with central sensitization (CS) in a sample of knee osteoarthritis, with and without CS, and fibromyalgia, and to compare their psychopathological profiles. Methods: The final sample consists of 19 patients with osteoarthritis and CS (mean 66.37 years ± 8.77), 41 osteoarthritis patients without CS (mean 66.8 ± 7.39 years), 47 fibromyalgia patients (mean 46.47 years ± 7.92) and 26 control subjects (mean 51.56 years ± 11.41). The psychopathological profile was evaluated with the Millon Multiaxial Clinical Inventory. Results: The average score of MCMI-III reflect higher scores in the fibromyalgia and osteoarthritis-CS groups. Patients with osteoarthritis-CS are more likely to report larger scores in Borderline and Major Depression scales. Fibromyalgia patients are more likely to report more increased scores in Somatoform and Major Depression, versus osteoarthritis-CS group. Fibromyalgia patients versus osteoarthritis without CS are more likely to report higher scores in Schizoid, Depression, Histrionic, Sadistic, Borderline, Somatoform, Posttraumatic Stress Disorder and Major Depression scales. Discussion: Patients with CS have less differences in their psychopathological profiles as well as in both osteoarthritis groups and greatest differences are obtained between the fibromyalgia and osteoarthritis without CS, so perhaps presence of CS is the key to differentiate those groups and not chronic pain. An exhaustive assessment brings more accurate psychopathological profiles, thus better psychological treatment could be applied.This work was partially supported by the Ministry of Economy and Competitiveness (Grant PSI2014-53524-P and PSI2017-83777) and the Agency of University and Research Funding Management of the Catalonia Government (Research Groups SGR2017-1198). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript